These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

372 related items for PubMed ID: 17762514

  • 21. The role of allopregnanolone in the anxiolytic-like effect of free and easy wanderer plus (FEWP), a polyherbal preparation.
    Qiu ZK, He JL, Liu X, Lai S, Ma JC, Zeng J, Li Y, Wu HW, Chen Y, Shen YG, Chen JS, Luo M.
    Neurosci Lett; 2015 May 19; 595():94-8. PubMed ID: 25800108
    [Abstract] [Full Text] [Related]

  • 22. Infusions of midazolam into the medial prefrontal cortex produce anxiolytic effects in the elevated plus-maze and shock-probe burying tests.
    Shah AA, Treit D.
    Brain Res; 2004 Jan 16; 996(1):31-40. PubMed ID: 14670628
    [Abstract] [Full Text] [Related]

  • 23. Behavioral and neurochemical effects of acute putrescine depletion by difluoromethylornithine in rats.
    Gupta N, Zhang H, Liu P.
    Neuroscience; 2009 Jul 07; 161(3):691-706. PubMed ID: 19348875
    [Abstract] [Full Text] [Related]

  • 24. Perinatal allopregnanolone influences prefrontal cortex structure, connectivity and behavior in adult rats.
    Grobin AC, Gizerian S, Lieberman JA, Morrow AL.
    Neuroscience; 2006 Jul 07; 138(3):809-19. PubMed ID: 16457952
    [Abstract] [Full Text] [Related]

  • 25. Blockade of fear-induced antinociception with intra-amygdala infusion of midazolam: Influence of prior test experience.
    Baptista D, Bussadori K, Nunes-de-Souza RL, Canto-de-Souza A.
    Brain Res; 2009 Oct 19; 1294():29-37. PubMed ID: 19635465
    [Abstract] [Full Text] [Related]

  • 26. Long-term administration with levonorgestrel decreases allopregnanolone levels and alters GABA(A) receptor subunit expression and anxiety-like behavior.
    Porcu P, Mostallino MC, Sogliano C, Santoru F, Berretti R, Concas A.
    Pharmacol Biochem Behav; 2012 Aug 19; 102(2):366-72. PubMed ID: 22634062
    [Abstract] [Full Text] [Related]

  • 27. CB1 receptor stimulation in specific brain areas differently modulate anxiety-related behaviour.
    Rubino T, Guidali C, Vigano D, Realini N, Valenti M, Massi P, Parolaro D.
    Neuropharmacology; 2008 Jan 19; 54(1):151-60. PubMed ID: 17692344
    [Abstract] [Full Text] [Related]

  • 28. Neonatal finasteride induces anxiogenic-like profile and deteriorates passive avoidance in adulthood after intrahippocampal neurosteroid administration.
    Martín-García E, Darbra S, Pallarés M.
    Neuroscience; 2008 Jul 17; 154(4):1497-505. PubMed ID: 18539400
    [Abstract] [Full Text] [Related]

  • 29. Anxiolytic-like effects of kappa-opioid receptor antagonists in models of unlearned and learned fear in rats.
    Knoll AT, Meloni EG, Thomas JB, Carroll FI, Carlezon WA.
    J Pharmacol Exp Ther; 2007 Dec 17; 323(3):838-45. PubMed ID: 17823306
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Translocator protein mediates the anxiolytic and antidepressant effects of midazolam.
    Qiu ZK, Li MS, He JL, Liu X, Zhang GH, Lai S, Ma JC, Zeng J, Li Y, Wu HW, Chen Y, Shen YG, Chen JS.
    Pharmacol Biochem Behav; 2015 Dec 17; 139(Pt A):77-83. PubMed ID: 26455280
    [Abstract] [Full Text] [Related]

  • 32. Antidepressant effect and changes of GABAA receptor gamma2 subunit mRNA after hippocampal administration of allopregnanolone in rats.
    Nin MS, Salles FB, Azeredo LA, Frazon AP, Gomez R, Barros HM.
    J Psychopharmacol; 2008 Jul 17; 22(5):477-85. PubMed ID: 18308780
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Anxiolytic-like effects and safety profile of a tryptic hydrolysate from bovine alpha s1-casein in rats.
    Messaoudi M, Lalonde R, Schroeder H, Desor D.
    Fundam Clin Pharmacol; 2009 Jun 17; 23(3):323-30. PubMed ID: 19453759
    [Abstract] [Full Text] [Related]

  • 37. Anxiolytic-like effects of substance P administration into the dorsal, but not ventral, hippocampus and its influence on serotonin.
    Carvalho MC, Masson S, Brandão ML, de Souza Silva MA.
    Peptides; 2008 Jul 17; 29(7):1191-200. PubMed ID: 18490080
    [Abstract] [Full Text] [Related]

  • 38. Selective antagonism of medial prefrontal cortex D4 receptors decreases fear-related behaviour in rats.
    Shah AA, Sjovold T, Treit D.
    Eur J Neurosci; 2004 Jun 17; 19(12):3393-7. PubMed ID: 15217397
    [Abstract] [Full Text] [Related]

  • 39. Evaluation of the anxiolytic effects of chrysin, a Passiflora incarnata extract, in the laboratory rat.
    Brown E', Hurd NS, McCall S, Ceremuga TE.
    AANA J; 2007 Oct 17; 75(5):333-7. PubMed ID: 17966676
    [Abstract] [Full Text] [Related]

  • 40. The NK1 receptor antagonist NKP608 lacks anxiolytic-like activity in Swiss-Webster mice exposed to the elevated plus-maze.
    Rodgers RJ, Gentsch C, Hoyer D, Bryant E, Green AJ, Kolokotroni KZ, Martin JL.
    Behav Brain Res; 2004 Sep 23; 154(1):183-92. PubMed ID: 15302124
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.